1. HlavsaMC, RobertsVA, AndersonAR, et al.Surveillance for waterborne disease outbreaks and other health events associated with recreational water – United States, 2007–2008. MMWR Surveill Summ2011;60:1.

2. KappusKD, LundgrenRGJr, JuranekDD, et al.Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg1994;50:705.

3. AminOM. Seasonal prevalence of intestinal parasites in the United States during 2000. Am J Trop Med Hyg2002;66:799.

4. McAuliffeGN, AndersonTP, StevensM, et al.Systematic application of multiplex PCR enhances the detection of bacteria, parasites, and viruses in stool samples. J Infect2013;67:122. S0163‐4453(13)00098‐4. CrossRef

5. StensvoldCR, NielsenHV. Comparison of microscopy and PCR for detection of intestinal parasites in Danish patients supports an incentive for molecular screening platforms. J Clin Microbiol2012;540.

6. StarkD, Al‐QassabSE, BarrattJL, et al.Evaluation of multiplex tandem real‐time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples. J Clin Microbiol2011;49:257. CrossRef

7. FotedarR, StarkD, BeebeN, et al.Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev2007;20:511. CrossRef

8. BrumptME. Étude sommaire de l'Entamoeba dispar n. sp. Amibe a kystes quadrinucléés, parasite de l'homme. Bull Acad Med (Paris)1925;94:943.

9. ClarkCG, DiamondLS. Ribosomal RNA genes of ‘pathogenic’ and ‘nonpathogenic’Entamoeba histolytica are distinct. Mol Biochem Parasitol1991;49:297. CrossRef

10. ShimokawaC, KabirM, TaniuchiM, et al.Entamoeba moshkovskii is associated with diarrhea in infants and causes diarrhea and colitis in mice. J Infect Dis2012;206:744. CrossRef

11. YakoobJ, AbbasZ, BegMA, et al.Entamoeba species associated with chronic diarrhoea in Pakistan. Epidemiol Infect2012;140:323. CrossRef

12. SmithJM, MeerovitchE. Primates as a source of Entamoeba histolytica, their zymodeme status and zoonotic potential. J Parasitol1985;71:751. CrossRef

13. StanleySLJr. Amebiasis. Lancet2003;361:1025. CrossRef

14. AnuarTS, Al‐MekhlafiHM, Abdul GhaniMK, et al.Molecular epidemiology of amoebiasis in Malaysia: highlighting the different risk factors of Entamoeba histolytica and Entamoeba dispar infections among Orang Asli communities. Int J Parasitol2012;42:1165. CrossRef

15. ElbakriA, SamieA, EzzedineS, et al.Differential detection of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in fecal samples by nested PCR in the United Arab Emirates (UAE). Acta Parasitol2013;58:185. CrossRef

16. HaqueR, AliIM, SackRB, et al.Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis2001;183:1787. CrossRef

17. Caballero‐SalcedoA, Viveros‐RogelM, SalvatierraB, et al.Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg1994;4:412.

18. KrogstadDJ, SpencerHCJr, HealyGR, et al.Amebiasis: epidemiologic studies in the United States, 1971–1974. Ann Intern Med1978;88:89. CrossRef

19. WeinkeT, Friedrich‐JaenickeB, HoppP, et al.Prevalence and clinical importance of Entamoeba histolytica in two high‐risk groups: travelers returning from the tropics and male homosexuals. J Infect Dis1990;161:1029. CrossRef

20. MathewsJM, MossDM, HealyGR, et al.Isoenzyme analysis of Entamoeba histolytica from homosexual men. J Infect Dis1986;153:793. CrossRef

21. DuggalP, GuoX, HaqueR, et al.A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest2011;121:1191. CrossRef

22. de LeonA. Pronostico tardio en el absceso hepatico amibiano. Arch Invest Med Mex1970;1(Suppl):205.

23. ChouduriG, PrakashV, KumarA, et al.Protective immunity to Entamoeba histolytica infection in subjects with anti‐amoebae antibodies residing in a hyperendemic zone. Scand J Infect Dis1991;23:771. CrossRef

24. Perez‐TamayoR. Pathology of amebiasis. In: Martinez‐PalomoA(ed). Amebiasis: Human Parasitic Diseases. Amsterdam: Elsevier Biomedical Press; 1986: 45.

25. CouncilmanWT, LaFleurHA. Amoebic dysentery. Johns Hopkins Hosp Rep1891;2:395.

26. BrandtH, Pérez TamayoR. Pathology of human amebiasis. Hum Pathol1970;1:351. CrossRef

27. JoyceMP, RavdinJI. Pathology of human amebiasis. In: RavdinJI(ed). Amebiasis: Human Infection by Entamoeba histolytica. New York: John Wiley & Sons; 1988: 129.

28. TsutsumiV. Pathology of experimental amebiasis. In: RavdinJI(ed). Amebiasis: Human Infection by Entamoeba histolytica. New York: John Wiley & Sons; 1988: 147.

29. LoftusB, AndersonI, DaviesR, et al.The genome of the protist parasite Entamoeba histolytica. Nature2005;433:865. CrossRef

30. WilsonIW, WeedallGD, HallN. Host‐Parasite interactions in Entamoeba histolytica and Entamoeba dispar: what have we learned from their genomes?Parasite Immunol2012;34:90. CrossRef

31. DebnathA, DasP, SajidM, et al.Identification of genomic responses to collagen binding by trophozoites of Entamoeba histolytica. J Infect Dis2004;190:448. CrossRef

32. MacFarlaneRC, SinghU. Identification of differentially expressed genes in virulent and nonvirulent Entamoeba species: potential implications for amebic pathogenesis. Infect Immun2006;74:340. CrossRef

33. DavisPH, SchulzeJ, StanleySLJr. Transcriptomic comparison of two Entamoeba histolytica strains with defined virulence phenotypes identifies new virulence factor candidates and key differences in the expression patterns of cysteine proteases, lectin light chains, and calmodulin. Mol Biochem Parasitol2007;151:118. CrossRef

34. MarionS, LaurentC, GuillenN. Signalization and cytoskeleton activity through myosin IB during the early steps of phagocytosis in Entamoeba histolytica: a proteomic approach. Cell Microbiol2005;7:1504. CrossRef

35. OkadaM, HustonCD, OueM, et al.Kinetics and strain variation of phagosome proteins of Entamoeba histolytica by proteomic analysis. Mol Biochem Parasitol2006;145:171. CrossRef

36. DavisPH, ZhangX, GuoJ, et al.Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence. Mol Microbiol2006;61:1523. CrossRef

37. DavisPH, ChenM, ZhangZ, et al.Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica aldohol dehydrogenase 3 in virulence. PLoS Negl Trop Dis2009;3:e415. CrossRef

38. RameshMA, MalikS‐B, LogsdonJM. A phylogenetic inventory of meiotic genes evidence for sex in Giardia and an early eukaryotic origin of meiosis. Curr Biol2005;15:185.

39. McCoyJJ, MannBJ, PetriWAJr. Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect Immun1994;62:3045.

40. KeeneWE, HidalgoME, OrozcoE, et al.Entamoeba histolytica: correlation of the cytopathic effect of virulent trophozoites with secretion of a cysteine proteinase. Exp Parasitol1990;71:199. CrossRef

41. TannichE, ScholzeH, NickelR, et al.Homologous cysteine proteinases of pathogenic and nonpathogenic Entamoeba histolytica. Differences in structure and expression. J Biol Chem1991;266:4798.

42. StanleySLJr, ZhangT, RubinD, et al.Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient (SCID) mice. Infect Immun1995;63:1587.

43. ZhangZ, YanL, WangL, et al.Entamoeba histolytica cysteine proteinases with interleukin‐1 beta converting enzyme activity cause intestinal inflammation and tissue damage in amoebiasis. Mol Microbiol2000;37:542. CrossRef

44. LeippeM, EbelS, SchoenbergerOL, et al.Pore‐forming peptide of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A1991;88:7659. CrossRef

45. LeippeM. Amoebapores. Parasitol Today1997;13:178. CrossRef

46. ZhangZ, StanleySLJr. Stereotypic and specific elements of the human colonic response to Entamoeba histolytica and Shigella flexneri. Cell Microbiol2004;6:535. CrossRef

47. PelosofLC, DavisPH, ZhangZ, et al.Co‐ordinate but disproportionate activation of apoptotic, regenerative and inflammatory pathways characterizes the liver response to acute amebic infection. Cell Microbiol2006;8:508. CrossRef

48. AdamsEB, MacLeodIN. Invasive amebiasis: amebic dysentery and its complications. Medicine1977;56:315.

49. StanleySLJr. Amoebiasis. Lancet2003;361:1025. CrossRef

50. ChunD, ChandrasomaP, KiyabuM. Fulminant amebic colitis: a morphologic study of 4 cases. Dis Colon Rectum1994;37:535. CrossRef

51. TuckerPC, WebsterPD, KilpatrickZM. Amebic colitis mistaken for inflammatory bowel disease. Arch Intern Med1975;135:681. CrossRef

52. KatzensteinD, RickersonV, BraudeA. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine1982;61:237. CrossRef

53. BarnesPF, DeCockKM, ReynoldsTN, et al.A comparison of amebic and pyogenic abscess of the liver. Medicine1987;66:472. CrossRef

54. AdamsEB, MacLeodIN. Invasive amebiasis: amebic liver abscess and its complications. Medicine1977;56:325.

55. ReedSL, BraudeAI. Extraintestinal disease: clinical syndromes, diagnostic profile, and therapy. In: RavdinJI(ed). Amebiasis: Human Infection by Entamoeba Histolytica. New York: John Wiley & Sons; 1988: 511.

56. Magana‐GarciaM, Arista‐ViverosA. Cutaneous amebiasis in children. Pediatr Dermatol1993;10:332.

57. PillaiDR, KeystoneJS, SheppardDC, et al.Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in the setting of nonendemicity. Clin Infect Dis1999;29:1315. CrossRef

58. HaqueR, KressK, WoodS, et al.Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose‐specific adhesin. J Infect Dis1993;167:247. CrossRef

59. Abd‐AllaMD, JacksonTFHG, GathiramV, et al.Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose‐inhibitable adherence protein antigen in sera and feces. J Clin Microbiol1993;31:2845.

60. GoninP, TrudelL. Detection and differentiation of Entamoeba histolytica and Entamoeba dispar isolates in clinical samples by PCR and enzyme‐linked immunosorbent assay. J Clin Microbiol2003;41:237. CrossRef

61. VisserLG, VerweijJJ, Van EsbroeckM, et al.Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a non‐endemic setting. Int J Med Microbiol2006;296:397. CrossRef

62. BlumencranzH, KasenL, RomeuJ, et al.The role of endoscopy in suspected amebiasis. J Gastroenterol1983;78:15.

63. HealyGR. Serology. In: RavdinJI(ed). Amebiasis: Human Infection by Entamoeba histolytica. New York: John Wiley & Sons; 1988: 650.

64. StanleySLJr, JacksonTFHG, ReedSL, et al.Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica protein. JAMA1991;266:1984. CrossRef

65. ZhangY, LiE, JacksonTFHG, et al.Use of a recombinant 170‐kilodalton surface antigen of Entamoeba histolytica for serodiagnosis of amebiasis and identification of immunodominant domains of the native molecule. J Clin Microbiol1992;30:2788.

66. FloresBM, ReedSL, RavdinJI, et al.Serologic reactivity to purified recombinant and native 29‐kilodalton peripheral membrane protein of pathogenic Entamoeba histolytica. J Clin Microbiol1993;31:1403.

67. StanleySLJr. Amebiasis. In: RakelRE(ed). Conn's Current Therapy. Philadelphia: WB Saunders; 1993: 60.

68. RavdinJI. Amebiasis. Clin Infect Dis1995;20:1453. CrossRef

69. PowellSJ. Drug trials in amoebiasis. Bull WHO1969;40:956.

70. LawfordR, SorrellTC. Amebic abscess of the spleen complicated by metronidazole‐induced neurotoxicity: case report. Clin Infect Dis1994;19:346. CrossRef

71. FungHB, DoanTL. Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther2005;27:1859. CrossRef

72. GonzalesML, DansLF, MartinezEG. Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev2009;(2):CD006085.

73. KananiSR, KnightR. Experiences with the use of metronidazole in the treatment of nondysenteric intestinal amoebiasis. Trans R Soc Trop Med Hyg1972;66:244. CrossRef

74. McAuleyJB, JuranekDD. Paromomycin in the treatment of mild‐to‐moderate intestinal amebiasis. Clin Infect Dis1992;15:551. CrossRef

75. AdamRD. Biology of Giardia lamblia. Clin Microbiol Rev2001;14:447. CrossRef

76. GillinFD, ReinerDS, GaultMJ, et al.Encystation and expression of cyst antigens by Giardia lamblia in vitro. Science1987;235:1040. CrossRef

77. GillinFD, ReinerDS, GaultMJ, et al.Encystation and expression of cyst antigens by Giardia lamblia in vitro. Science1987;235:1040. CrossRef

78. RendtorffRC. The experimental transmission of the human intestinal protozoan parasites: II. Giardia lamblia cysts given as capsules. Am J Hyg1954;59:209.

79. LengerichEJ, AddissDG, JuranekDD. Severe giardiasis in the United States. Clin Infect Dis1994;18:760. CrossRef

80. DennisDT, SmithRP, WelchJJ, et al.Endemic giardiasis in New Hampshire: a case‐control study of environmental risks. J Infect Dis1993;167:1391. CrossRef

81. HlavsaMC, WatsonJC, BeachMJ. Giardiasis surveillance – United States, 1998–2002. MMWR Surveill Summ2005;54:9.

82. YoderJS, GarganoJW, WallaceRM, et al.Giardiasis surveillance – United States, 2009–2010. MMWR Surveill Summ2012;61:13.

83. KaranisP, KourentiC, SmithH. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J Water Health2007;5:1. CrossRef

84. HunterPR, ThompsonRC. The zoonotic transmission of Giardia and Cryptosporidium. Int J Parasitol2005;35:1181. CrossRef

85. RoseJB, SlifkoTR. Giardia, Cryptosporidium, and Cyclospora and their impact on foods: a review. J Food Prot1999;62:1059.

86. AnkarklevJ, Jerlström‐HultqvistJ, RingqvistE, et al.Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol2010;8:413.

87. ScottKG, YuLC, BuretAG. Role of CD8+ and CD4+ T lymphocytes in jejunal mucosal injury during murine giardiasis. Infect Immun2004;72:3536. CrossRef

88. KaurH, GhoshS, SamraH, et al.Identification and characterization of an excretory‐secretory product from Giardia lamblia. Parasitology2001;123:347. CrossRef

89. ShantJ, GhoshS, BhattacharyyaS, et al.The alteration in signal transduction parameters induced by the excretory‐secretory product from Giardia lamblia. Parasitology2004;129:421. CrossRef

90. ScottKG, MeddingsJB, KirkDR, et al.Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase‐dependent fashion. Gastroenterology2002;123:1179. CrossRef

91. MayrhoferG, AndrewsRH, EyPL, et al.Division of Giardia isolates from humans into two genetically distinct assemblages by electrophoretic analysis of enzymes encoded at 27 loci and comparison with Giardia muris. Parasitology1995;111:11. CrossRef

92. CacciòSM, RyanU. Molecular epidemiology of giardiasis. Mol Biochem Parasitol2008;160:75. CrossRef

93. UpcroftJA, KrauerKG, UpcroftP. Chromosome sequence maps of the Giardia lamblia assemblage A isolate WB. Trends Parasitol2010;26:484. CrossRef

94. Jerlström‐HultqvistJ, AnkarklevJ, SvärdSG. Is human giardiasis caused by two different Giardia species?Gut Microbes2010;1:379. CrossRef

95. GeurdenT, LeveckeB, CaccióSM, et al.Multilocus genotyping of Cryptosporidium and Giardia in non‐outbreak related cases of diarrhoea in human patients in Belgium. Parasitology2009;136:1161. CrossRef

96. EckmannL. Mucosal defences against Giardia. Parasite Immunol2003;25:259. CrossRef

97. FaubertG. Immune response to Giardia duodenalis. Clin Microbiol Rev2000;13:35. CrossRef

98. DavidsBJ, PalmJE, HousleyMP, et al.Polymeric immunoglobulin receptor in intestinal immune defense against the lumen‐dwelling protozoan parasite Giardia. J Immunol2006;177:6281. CrossRef

99. HermansPE, Diaz‐BuxoJA, StoboJD. Idiopathic late‐onset immunoglobulin deficiency: clinical observations in 50 patients. Am J Med1976;61:221. CrossRef

100. LoGalboPR, SampsonHA, BuckleyRH. Symptomatic giardiasis in three patients with X‐linked agammaglobulinemia. J Pediatr1982;101:78. CrossRef

101. SingerSM, NashTE. T‐cell dependent control of acute Giardia lamblia infections in mice. Infect Immun2000;68:170. CrossRef

102. JanoffEN, SmithPD, BlaserMJ. Acute antibody responses to Giardia lamblia are depressed in patients with AIDS. J Infect Dis1988;157:798. CrossRef

103. WalterspielJN, MorrowAL, GuerreroML, et al.Secretory anti‐Giardia lamblia antibodies in human milk: protective effect against diarrhea. Pediatrics1994;93:28.

104. NashTE, HerringtonDA, LosonskyGA, et al.Experimental human infections with Giardia lamblia. J Infect Dis1987;156:974. CrossRef

105. JokipiiAM, JokipiiL. Prepatency of giardiasis. Lancet1977;1:1095. CrossRef

106. LopezCE, DykesAC, JuranekDD, et al.Waterborne giardiasis: a community wide outbreak of disease and a high rate of asymptomatic infection. Am J Epidemiol1980;112:495.

107. MooreGT, CrossWM, McGuireD, et al.Epidemic giardiasis at a ski resort. N Engl J Med1969;281:402. CrossRef

108. BarbourAG, NicholsCR, FukushimaT. An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg1976;25:384.

109. WensaasKA, LangelandN, HanevikK, et al.Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut2012;61:214. CrossRef

110. SpillerR, LamC. An update on post‐infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil2012;18:258. CrossRef

111. HermansPE, HuizengaKA, HoffmanHN, et al.Dysgammaglobulinemia associated with nodular lymphoid hyperplasia of the small intestine. Am J Med1966;40:78. CrossRef

112. WardH, JalanKN, MaitraTK, et al.Small intestinal nodular lymphoid hyperplasia in patients with giardiasis and normal serum immunoglobulins. Gut1983;24:120. CrossRef

113. DoglioniC, De BoniM, CieloR, et al.Gastric giardiasis. J Clin Pathol1992;45:964. CrossRef

114. ShawRA, StevensMB. The reactive arthritis of giardiasis. JAMA1987;258:2734. CrossRef

115. ClyneCA, EliopoulosGM. Fever and urticaria in acute giardiasis. Arch Intern Med1989;149:939. CrossRef

116. AronsonNE, CheneyC, RhollV, et al.Biliary giardiasis in a patient with human immunodeficiency virus. J Clin Gastroenterol2001;33:167. CrossRef

117. ChurchD, MillerK, LichtenfeldA, et al.Screening for Giardia/Cryptosporidium infections using an enzyme immunoassay in a centralized regional microbiology laboratory. Arch Pathol Lab Med2005;129:754.

118. HansonKL, CartwrightCP. Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia. J Clin Microbiol2001;39:474. CrossRef

119. OberhuberG, StolteM. Symptoms in patients with giardiasis undergoing upper gastrointestinal endoscopy. Endoscopy1997;29:716. CrossRef

120. GrazioliB, MateraG, LarattaC, et al.Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol2006;12:1941.

121. HuangDB, WhiteAC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am2006;35:291. CrossRef

122. HallA, NaharQ. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg1993;87:84. CrossRef

123. AbboudP, LeméeV, GargalaG, et al.Successful treatment of metronidazole‐ and albendazole‐resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis2001;32:1792. CrossRef

124. FoxLM, SaravolatzLD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis2005;40:1173. CrossRef

125. GranadosCE, ReveizL, UribeLG, et al.Drugs for treating giardiasis. Cochrane Database Syst Rev2012;(12):CD007787.

126. SaffarMJ, QaffariJ, KhalilianAR, et al.Rapid reinfection by Giardia lamblia after treatment in a hyperendemic area: the case against treatment. East Mediterr Health J2005;11:73.

127. StenzelDJ, BorehamPF. Blastocystis hominis revisited. Clin Microbiol Rev1996;9:563.

128. DenoeudF, RousselM, NoelB, et al.Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol2011;12:R29. CrossRef

129. KeystoneJS. Blastocystis hominis and traveler's diarrhea. Clin Infect Dis1995;21:102. CrossRef

130. MarkellEK. Is there any reason to continue treating Blastocystis infections?Clin Infect Dis1995;21:104. CrossRef

131. StarkD, van HalS, MarriottD, et al.Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol2007;37:11. CrossRef

132. PoirierP, WawrzyniakI, VivarèsCP, et al.New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog2012;8:e1002545. CrossRef

133. HeylandK, FriedtM, BuehrP, et al.No advantage for antibiotic treatment over placebo in Blastocystis hominis‐positive children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr2012;54:677. CrossRef

134. MoghaddamDD, GhadirianE, AzamiM. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol Res2005;96:273. CrossRef

135. StarkD, BeebeN, MarriottD, et al.Dientamoebiasis: clinical importance and recent advances. Trends Parasitol2006;22:92. CrossRef

136. JohnsonEH, WindsorJJ, ClarkCG. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev2004;17:553. CrossRef

137. EngsbroAL, StensvoldCR, NielsenHV, et al.Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg2012;87:1046. CrossRef

138. SchusterFL, Ramirez‐AvilaL. Current world status of Balantidium coli. Clin Microbiol Rev2008;21:626. CrossRef

139. WalzerPD, JudsonFN, MurphyKB, et al.Balantidiasis outbreak in Truk. Am J Trop Med Hyg1973;22:33.

140. DoddLG. Balantidium coli infestation as a cause of acute appendicitis. J Infect Dis1991;163:1392. CrossRef

141. AbioyeAA, EjeckamGC. Silent appendicitis in Ibadan, Nigeria. Study of 184 consecutive autopsies. Int Surg1977;62:501.

142. LadasSD, SavvaS, FrydasA, et al.Invasive balantidiasis presented as chronic colitis and lung involvement. Dig Dis Sci1989;34:1621. CrossRef

143. SamranwetayaP, DechakaisayaS, TangchaiP. Fatal balantidial colitis. Report of a case. J Med Assoc Thai1972;55:259.

144. GoodgameRW. Understanding intestinal spore‐forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann Intern Med1996;124:429. CrossRef

145. TyzzerEE. A sporozoan found in the peptic glands of the common mouse. Proc Soc Exp Biol Med1907;5:12. CrossRef

146. NimeFA, BurekJD, PageDL, et al.Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology1976;70:592.

147. MeiselJL, PereraDR, MeligroC, et al.Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology1976;70:1156.

148. Centers for Disease Control and Prevention. Cryptosporidiosis: an assessment of chemotherapy of males with acquired immune deficiency syndrome (AIDS). MMWR Morb Mortal Wkly Rep1982;31:589.

149. Morgan‐RyanUM, FallA, WardLA, et al.Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol2002;49:433. CrossRef

150. ElwinK, HadfieldSJ, RobinsonG, et al.The epidemiology of sporadic human infections with unusual cryptosporidia detected during routine typing in England and Wales, 2000–2008. Epidemiol Infect2012;140:673. CrossRef

151. BartaJR, ThompsonRCA. What is Cryptosporidium? Reappraising its biology and phylogenetic affinities. Trends Parasitol2006;22:463. CrossRef

152. ChalmersRM, DaviesAP. Minireview: clinical cryptosporidiosis. Exp Parasitol2010;124:138. CrossRef

153. YoderJS, WallaceRM, CollierSA. Cryptosporidiosis surveillance – United States, 2009–2010. MMWR Surveill Summ2012;61:1.

154. DziubanEJ, LiangJL, CraunGF, et al.Surveillance for waterborne disease and outbreaks associated with recreational water – United States, 2003–2004. Morb Mortal Wkly Rep Surveill Summ2006;55:1.

155. SmithA, ReacherM, SmerdonW, et al.Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992–2003. Epidemiol Infect2006;134:1141. CrossRef

156. ThompsonRC, OlsonME, ZhuG, et al.Cryptosporidium and cryptosporidiosis. Adv Parasitol2005;59:77. CrossRef

157. UngarBL, MulliganM, NutmanTB. Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa. Arch Intern Med1989;149:894. CrossRef

158. KuhlsTL, MosierDA, CrawfordDL, et al.Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis1994;18:731. CrossRef

159. LengerichEJ, AddissDG, MarxJJ, et al.Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J Infect Dis1993;167:1252. CrossRef

160. UngarBL, GilmanRH, LanataCF, et al.Seroepidemiology of Cryptosporidium infection in two Latin American populations. J Infect Dis1988;157:551. CrossRef

161. NewmanRD, ZuSX, WuhibT, et al.Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil. Ann Intern Med1994;120:500. CrossRef

162. CordellRL, AddissDG. Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control. Pediatr Infect Dis J1994;13:310. CrossRef

163. MacKenzieWR, SchellWL, BlairKA, et al.Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis1995;21:57. CrossRef

164. KochKL, PhillipsDJ, AberRC, et al.Cryptosporidiosis in hospital personnel. Evidence for person‐to‐person transmission. Ann Intern Med1985;102:593. CrossRef

165. WeitzelT, WichmannO, MuhlbergerN, et al.Epidemiological and clinical features of travel‐associated cryptosporidiosis. Clin Microbiol Infect2006;12:921. CrossRef

166. WetzelDM, SchmidtJ, KuhlenschmidtMS, et al.Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites. Infect Immun2005;73:5379. CrossRef

167. McColeDF, EckmannL, LaurentF, et al.Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun2000;68:1710. CrossRef

168. ChenXM, KeithlyJS, PayaCV, et al.Cryptosporidiosis. N Engl J Med2002;346:1723. CrossRef

169. AbrahamsenMS, TempletonTJ, EnomotoS, et al.Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science2004;304:441. CrossRef

170. XuP, WidmerG, WangY, et al.The genome of Cryptosporidium hominis. Nature2004;431:1107. CrossRef

171. GentaRM, ChappellCL, WhiteACJr, et al.Duodenal morphology and intensity of infection in AIDS‐related intestinal cryptosporidiosis. Gastroenterology1993;105:1769.

172. GoodgameRW, KimballK, OuCN, et al.Intestinal function and injury in acquired immunodeficiency syndrome‐related cryptosporidiosis. Gastroenterology1995;125:1075. CrossRef

173. Gomez MoralesMA, AusielloCM, GuarinoA, et al.Severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report. Clin Infect Dis1996;22:848. CrossRef

174. ChenW, HarpJA, HarmsenAG. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun1993;61:3928.

175. AguirreSA, MasonPH, PerrymanLE. Susceptibility of major histocompatibility complex (MHC) class I and MHC class II‐deficient mice to Cryptosporidium parvum infection. Infect Immun1994;62:697.

176. SchmidtW, WahnschaffeU, SchaferM, et al.Rapid increase in mucosal CD4 T cells followed by clearance of cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology2001;120:984. CrossRef

177. HuppmannAR, OrensteinJM. Opportunistic disorders of the gastrointestinal tract in the age of highly active antiretroviral therapy. Hum Pathol2010;41:1777. CrossRef

178. DuPontHL, ChappellCL, SterlingCR, et al.The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med1995;332:855. CrossRef

179. ChappellCL, OkhuysenPC, SterlingCR, et al.Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis1996;173:232. CrossRef

180. ChappellCL, OkhuysenPC, Langer‐CurryR, et al.Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg2006;75:851.

181. JokipiiL, JokipiiAM. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med1986;315:1643. CrossRef

182. HawkinsSP, ThomasRP, TesdateC. Acute pancreatitis: a new finding in Cryptosporidium enteritis. Br Med J1987;294:483. CrossRef

183. HayEM, WinfieldJ, McKendrickMW. Reactive arthritis associated with Cryptosporidium enteritis. Br Med J1987;295:248. CrossRef

184. ValdezLM, DangH, OkhuysenPC, et al.Flow cytometric detection of Cryptosporidium oocysts in human stool samples. J Clin Microbiol1997;35:2013.

185. HuJ, FengY, OngSL, et al.Improvement of recoveries for the determination of protozoa Cryptosporidium and Giardia in water using method 1623. J Microbiol Methods2004;58:321. CrossRef

186. ConnollyGM, EllisDS, WilliamsJE, et al.Use of electron microscopy in examination of faeces and rectal and jejunal biopsy specimens. J Clin Pathol1991;44:313. CrossRef

187. SmithHV, CorcoranGD. New drugs and treatment for cryptosporidiosis. Curr Opin Infect Dis2004;17:557. CrossRef

188. FoxLM, SaravolatzLD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis2005;40:1173. CrossRef

189. VandenbergO, RobberechtF, DaubyN, et al.Management of a Cryptosporidium hominis outbreak in a day‐care center. Pediatr Infect Dis J2012;31:10. CrossRef

190. OrtegaYR, SanchezR. Update on Cyclospora cayetanensis, a food‐borne and waterborne parasite. Clin Microbiol Rev2010;23:218. CrossRef

191. HerwaldtBL. Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis2000;31:1040. CrossRef

192. OrtegaYR, SterlingCR, GilmanRH, et al.Cyclospora species – a new protozoan pathogen of humans. N Engl J Med1993;328:1308. CrossRef

193. SunT, IlardiCF, AsnisD, et al.Light and electron microscopic identification of Cyclospora species in the small intestine. Evidence of the presence of asexual life cycle in human host. Am J Clin Pathol1996;105:216.

194. RelmanDA, SchmidtTM, GajadharA, et al.Molecular phylogenetic analysis of Cyclospora, the human intestinal pathogen, suggests that it is closely related to Eimeria species. J Infect Dis1996;173:440. CrossRef

195. ZerpaR, UchimaN, HuichoL. Cyclospora cayetanensis associated with watery diarrhoea in Peruvian patients. J Trop Med Hyg1995;98:325.

196. MarekA, McCollK, GoingJ, et al.What a professor learned about Cyclospora cayetanensis by attending Digestive Diseases Week conference in Chicago. Am J Gastroenterol2012;107:1109. CrossRef

197. BrandS, OchsenkühnT, HogardtM. Indigestion after Digestive Disease Week (DDW): be aware of the “Golden Raspberry Award” at DDW and Cyclospora cayetanensis. Am J Gastroenterol2012;107:1927. CrossRef

198. HogeCW, ShlimDR, RajahR, et al.Epidemiology of diarrhoeal illness associated with coccidian‐like organism among travelers and foreign residents in Nepal. Lancet1993;341:1175. CrossRef

199. Centers for Disease Control and Prevention. Outbreak of cyclosporiasis associated with snow peas – Pennsylvania, 2004. MMWR Morb Mortal Wkly Rep2004;53:876.

200. Alfano‐SobseyEM, EberhardML, SeedJR, et al.Human challenge pilot study with Cyclospora cayetanensis. Emerg Infect Dis2004;10:726. CrossRef

201. ShlimDR, CohenMT, EatonM, et al.An alga‐like organism associated with an outbreak of prolonged diarrhea among foreigners in Nepal. Am J Trop Med Hyg1991;45:383.

202. RaboldJG, HogeCW, ShlimDR, et al.Cyclospora outbreak associated with chlorinated drinking water. Lancet1994;344:1360. CrossRef

203. ConnorBA, ShlimDR, ScholesJV, et al.Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidia‐like body. Ann Intern Med1993;119:377. CrossRef

204. OrtegaYR, NagleR, GilmanRH, et al.Pathologic and clinical findings in patients with cyclosporiasis and a description of intracellular parasite life‐cycle stages. J Infect Dis1997;176:1584. CrossRef

205. Pinge‐SuttorV, DouglasC, WettsteinA. Cyclospora infection masquerading as coeliac disease. Med J Aust2004;180:295.

206. VerdierRI, FitzgeraldDW, JohnsonWDJr, et al.Trimethoprim‐sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV‐infected patients: a randomized, controlled trial. Ann Intern Med2000;132:885. CrossRef

207. ZimmerSM, SchuetzAN, Franco‐ParedesC. Efficacy of nitazoxanide for cyclosporiasis in patients with sulfa allergy. Clin Infect Dis2007;44:466. CrossRef

208. JeffreyG. Epidemiologic considerations of isosporiasis in a school for mental defectives. Am J Hyg1958;67:251.

209. FaustE, GiraldoL, CaciedoG, et al.Human isosporiasis in the Western hemisphere. Am J Trop Med Hyg1961;10:341.

210. CarrenoRA, SchnitzlerBE, JeffriesAC, et al.Phylogenetic analysis of coccidia based on 18S rDNA sequence comparison indicates that Isospora is most closely related to Toxoplasma and Neospora. J Eukaryot Microbiol1998;45:184. CrossRef

211. FranzenC, MullerA, BialekR, et al.Taxonomic position of the human intestinal protozoan parasite Isospora belli as based on ribosomal RNA sequences. Parasitol Res2000;86:669. CrossRef

212. LindsayDS, DubeyJP, BlagburnBL. Biology of Isospora spp. from humans, nonhuman primates and domestic animals. Clin Microbiol Rev1997;10:19.

213. DeHovitzJA, PapeJW, BoncyM, et al.Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med1986;315:88. CrossRef

214. UslucaS, IncebozT, UnekT, et al.Isospora belli in a patient with liver transplantation. Turkiye Parazitol Derg2012;36:247. CrossRef

215. GruzF, FuxmanC, ErreaA, et al.Isospora belli infection after isolated intestinal transplant. Transpl Infect Dis2010;12:69. CrossRef

216. SilvaGB, FernandesKP, SegundoGR, et al.Common variable immunodeficiency and isosporiasis: first report case. Rev Soc Bras Med Trop2012;45:768. CrossRef

217. NavaneethanU, VenkateshPG, Downs‐KellyE. Isospora belli superinfection in a patient with eosinophilic gastroenteritis – a diagnostic challenge. J Crohns Colitis2012;6:236. CrossRef

218. SteinJ, TannichE, HartmannF. An unusual complication in ulcerative colitis during treatment with azathioprine and infliximab: Isospora belli as ‘Casus belli’. BMJ Case Rep2013;2013:●●.

219. BialekR, OverkampD, RettigI, et al.Case report: nitazoxanide treatment failure in chronic isosporiasis. Am J Trop Med Hyg2001;65:94.

220. BoylesTH, BlackJ, MeintjesG, et al.Failure to eradicate Isospora belli diarrhoea despite immune reconstitution in adults with HIV – a case series. PLoS ONE2012;7:e42844. CrossRef